Skip to main content

Table 1 Demographic and clinical characteristics among patients with prostate cancer (N = 452) according to age group, from the Martinique Cancer Registry, 2013

From: Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean

Characteristics

All

≤ 64 years

65–74 years

≥ 75 years

P

n

%

n

%

n

%

n

%

452

100.0

183

40.5

178

39.4

91

20.1

Symptoms at diagnosis

        

0.024

 Yes

103

28.5

35

23.8

38

26.8

30

41.1

 

 No

259

71.5

112

76.2

104

73.2

43

58.9

 

 Unknown

90

–

36

–

36

–

18

–

 

Clinical stage at diagnosis

        

0.0837

 T1N0M0

168

43.6

78

49.1

63

41.4

27

36.5

 

 T2N0M0

121

31.4

46

28.9

48

31.6

27

36.5

 

 T3/T4N0M0

43

11.2

22

13.8

15

9.9

6

8.1

 

 N+/M+

53

13.8

13

8.2

26

17.1

14

18.9

 

 Unknown

67

–

24

–

26

–

17

–

 

Prostate Specific Antigen (ng/ml)

        

0.17

 <  4

19

4.2

12

6.6

4

2.2

3

3.3

 

 4 ≥ PSA > 10

263

58.2

115

62.8

102

57.3

46

50.5

 

 10 ≥ PSA > 20

95

21.0

30

16.4

43

24.2

22

24.2

 

 20 ≥ PSA > 100

46

10.2

17

9.3

17

9.6

12

13.2

 

 ≥ 100 ng/ml

29

6.4

9

4.9

12

6.7

8

8.8

 

Gleason grade group

        

0.003

 Group 1 (3 + 3)

152

34.0

79

43.7

56

31.8

17

18.9

 

 Group 2 (3 + 4)

117

26.2

46

25.4

45

25.5

26

28.9

 

 Group 3 (4 + 3)

84

18.8

31

17.1

36

20.5

17

18.9

 

 Group 4 (8)

48

10.7

13

7.2

19

10.8

16

17.8

 

 Group 5 (9 or 10)

46

10.3

12

6.6

20

11.4

14

15.5

 

 Unknown

5

–

2

–

2

–

1

–

 

Risk groups

        

0.0129

 Low

69

17.9

40

25.2

22

14.5

7

9.5

 

 Intermediate

140

36.4

57

35.8

58

38.1

25

33.8

 

 High

123

31.9

49

30.8

46

30.3

28

37.8

 

 Regional/metastatic

53

13.8

13

8.2

26

17.1

14

18.9

 

 Unknown

67

–

24

–

26

–

17

–

Â